RESUMEN
Bilateral sight threatening macular and optic nerve inflammation may occur with dengue fever, necessitating the use of systemic steroids. We report a case of bilateral dengue maculopathy in an elderly woman managed with targeted intravitreal steroid therapy. A 63-year-old woman presented with acute-onset painless diminution of vision in both eyes following a dengue fever episode. She had bilateral foveal inflammatory lesions, macular oedema, small vessel occlusions at the macula and scattered retinal haemorrhages and cotton-wool spots. Following systemic evaluation, intravitreal triamcinolone acetonide injection was performed in both eyes at an interval of 3 days. The foveal lesion and macular oedema resolved quickly in both eyes with a normal foveal architecture at the end of 6-week follow-up. The visual acuity improved considerably in both eyes. Inflammatory retinopathy in dengue fever may be managed with a targeted intravitreal steroid injection approach.
Asunto(s)
Dengue/complicaciones , Glucocorticoides/administración & dosificación , Edema Macular/tratamiento farmacológico , Edema Macular/virología , Triamcinolona Acetonida/administración & dosificación , Dengue/diagnóstico , Dengue/terapia , Femenino , Humanos , Inyecciones Intravítreas , Edema Macular/diagnóstico , Persona de Mediana EdadRESUMEN
Importance: Survivors of Ebola virus disease (EVD) may experience ocular sequelae. Comparison with antibody-negative individuals from the local population is required to characterize the disease. Objective: To assess features of ophthalmic disease specific to EVD. Design, Setting, and Participants: This baseline cross-sectional analysis of survivors of EVD and their close contacts was conducted within PREVAIL III, a 5-year, longitudinal cohort study. Participants who enrolled at John F. Kennedy Medical Center in Liberia, West Africa from June 2015 to March 2016 were included in this analysis. Close contacts were defined as household members or sex partners of survivors of EVD. Data were analyzed from July 2016 to July 2020. Exposures: All participants, both survivors and close contacts, underwent testing of IgG antibody levels against Ebola virus surface glycoprotein. Main Outcomes and Measures: Ocular symptoms, anterior and posterior ophthalmologic examination findings, and optical coherence tomography images were compared between antibody-positive survivors and antibody-negative close contacts. Results: A total of 564 antibody-positive survivors (320 [56.7%] female; mean [SD] age, 30.3 [14.0] years) and 635 antibody-negative close contacts (347 [54.6%] female; mean [SD] age, 25.8 [15.5] years) were enrolled in this study. Survivors were more likely to demonstrate color vision deficit (28.9% vs 19.0%, odds ratio [OR], 1.6; 95% CI, 1.2-2.1) and lower intraocular pressure (12.4 vs 13.5 mm Hg; mean difference, -1.2 mm Hg; 95% CI, -1.6 to -0.8 mm Hg) compared with close contacts. Dilated fundus examination revealed a higher percentage of vitreous cells (7.8% vs 0.5%; OR, 16.6; 95% CI, 5.0-55.2) and macular scars (4.6% vs 1.6%; OR, 2.8; 95% CI, 1.4-5.5) in survivors than in close contacts. Uveitis was present in 26.4% of survivors and 12.1% of close contacts (OR, 2.4; 95% CI, 1.8-3.2). Among all participants with uveitis, survivors were more likely than close contacts to have intermediate uveitis (34.2% vs 6.5% of all cases; OR, 7.8; 95% CI, 3.1-19.7) and had thicker mean central subfield thickness on optical coherence tomography (222 vs 212 µm; mean difference, 14.4 µm; 95% CI, 1.9-26.9 µm). Conclusions and Relevance: In this cross-sectional study, survivors of EVD had a distinct spectrum of ocular and neuro-ophthalmologic findings compared with close contacts that potentially require medical and surgical treatment.
Asunto(s)
Oftalmopatías/virología , Fiebre Hemorrágica Ebola/complicaciones , Sobrevivientes , Adulto , Cicatriz/virología , Defectos de la Visión Cromática/virología , Estudios Transversales , Oftalmopatías/diagnóstico por imagen , Femenino , Humanos , Presión Intraocular , Liberia , Estudios Longitudinales , Edema Macular/virología , Masculino , Tomografía de Coherencia Óptica , Uveítis/virologíaAsunto(s)
Infecciones Virales del Ojo/diagnóstico , Herpes Simple/diagnóstico , Herpesvirus Humano 1/aislamiento & purificación , Edema Macular/diagnóstico , Síndrome de Necrosis Retiniana Aguda/diagnóstico , Aciclovir/uso terapéutico , Administración Oral , Antivirales/uso terapéutico , Humor Acuoso/virología , ADN Viral/genética , Quimioterapia Combinada , Infecciones Virales del Ojo/tratamiento farmacológico , Infecciones Virales del Ojo/virología , Femenino , Angiografía con Fluoresceína , Ganciclovir/uso terapéutico , Herpes Simple/tratamiento farmacológico , Herpes Simple/virología , Herpesvirus Humano 1/genética , Humanos , Infusiones Intravenosas , Inyecciones Intravítreas , Edema Macular/tratamiento farmacológico , Edema Macular/virología , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Prednisolona/uso terapéutico , Desprendimiento de Retina/diagnóstico , Desprendimiento de Retina/tratamiento farmacológico , Desprendimiento de Retina/virología , Síndrome de Necrosis Retiniana Aguda/tratamiento farmacológico , Síndrome de Necrosis Retiniana Aguda/virología , Tomografía de Coherencia ÓpticaRESUMEN
PURPOSE: Cystoid macular edema (CME) is a severe complication and a major cause of visual loss in patients with intraocular infection. In this type of CME, therapeutic strategies remain controversial. We aimed to investigate the efficacy and tolerability of interferon (IFN)-α2a in cystoid macular edema caused by intraocular infection. METHODS: In this retrospective, noncomparative, interventional case series, 5 patients (6 eyes) who were diagnosed with intraocular infection with chronic CME were included. Interferon-α2a (3 million units 3 times a week) was administered subcutaneously. Clinical observations were recorded before and after treatment. RESULTS: The average duration of CME before treatment with IFN-α was 26 months. According to the preset criteria, IFN-α2a therapy was shown to be effective in 2 patients (3 eyes), effective dose-dependent in 2 patients, and partly effective in 1 patient, and was well-tolerated in 4 patients. The most common side effect was flu-like symptoms. CONCLUSIONS: Interferon α-2a may be an effective alternative treatment for CME due to intraocular infection that is resistant to other treatment. Studies with larger sample sizes are required to confirm this conclusion.
Asunto(s)
Antivirales/uso terapéutico , Infecciones Virales del Ojo/tratamiento farmacológico , Interferón-alfa/uso terapéutico , Edema Macular/tratamiento farmacológico , Adulto , Anciano , Antivirales/efectos adversos , Enfermedad Crónica , Infecciones Virales del Ojo/diagnóstico , Infecciones Virales del Ojo/virología , Femenino , Glucocorticoides/uso terapéutico , Humanos , Inyecciones Subcutáneas , Interferón alfa-2 , Interferón-alfa/efectos adversos , Edema Macular/diagnóstico , Edema Macular/virología , Masculino , Persona de Mediana Edad , Proteínas Recombinantes/efectos adversos , Proteínas Recombinantes/uso terapéutico , Estudios Retrospectivos , Tomografía de Coherencia Óptica , Agudeza Visual , Adulto JovenRESUMEN
PURPOSE: We sought to investigate and describe the clinical spectrum of posterior segment abnormalities in immunocompetent patients presenting with CMV-associated anterior uveitis. METHODS: This was a prospective study conducted at the Singapore National Eye Centre, a tertiary referral centre, from August 2010 to June 2011. Eleven eyes of eleven patients with CMV anterior uveitis confirmed by polymerase chain reaction on aqueous humor sampling were recruited based on the study criteria. Patients were recruited from a single uveitis specialist clinic and underwent aqueous humor sampling and fluorescein and indocyanine green angiography as well as optical coherence tomography. They were further evaluated by the Infectious Disease physician for immunocompetence. RESULTS: Mean presenting visual acuity was logMAR 0.35 ± 0.29. The main presenting complaints were blurring of vision, eye redness, and pain. Anterior chamber cellular activity was present in all cases. Fine diffuse keratic precipitates (KPs) were present in 10 eyes, and the remaining one eye had mutton fat KPs. Iris changes were present in three eyes. Intraocular pressure (IOP) was elevated in nine eyes (mean presenting IOP was 40.2 ± 16.8 mmHg). In the posterior segment, none of the eyes had evidence of retinitis or hemorrhage. Posterior segment abnormalities were present in six eyes (macular edema, disc leakage, epiretinal membrane, phlebitis). Eight eyes also had prolonged arm to retina time (mean 24.8 ± 10.6 s) on fluorescein angiography. Indocyanine green angiography was unremarkable. CONCLUSION: Posterior segment manifestations can be seen in a proportion of immunocompetent patients with CMV anterior uveitis. The underlying mechanism remains to be determined.
Asunto(s)
Infecciones por Citomegalovirus/diagnóstico , Membrana Epirretinal/diagnóstico , Infecciones Virales del Ojo/diagnóstico , Edema Macular/diagnóstico , Vasculitis Retiniana/diagnóstico , Uveítis Anterior/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Humor Acuoso/virología , Colorantes , Infecciones por Citomegalovirus/virología , Membrana Epirretinal/virología , Infecciones Virales del Ojo/virología , Femenino , Angiografía con Fluoresceína , Humanos , Inmunocompetencia , Verde de Indocianina , Presión Intraocular/fisiología , Edema Macular/virología , Masculino , Persona de Mediana Edad , Proyectos Piloto , Reacción en Cadena de la Polimerasa , Estudios Prospectivos , Vasculitis Retiniana/virología , Tomografía de Coherencia Óptica , Uveítis Anterior/virología , Agudeza Visual/fisiologíaRESUMEN
Optic nerve involvement may occur in various infectious diseases, but is rarely reported after infection by the human immunodeficiency virus (HIV). We report the atypical case of a 38-year-old patient in whom the presenting features of HIV infection were due to a bilateral optic neuropathy associated with macular subretinal fluid and cystoid macular edema, which responded well to antiretroviral therapy.
Asunto(s)
Infecciones por VIH/complicaciones , Edema Macular/virología , Enfermedades del Nervio Óptico/virología , Trastornos de la Visión/virología , Adulto , Infecciones por VIH/patología , Humanos , Mácula Lútea/patología , Edema Macular/patología , Masculino , Nervio Óptico/patología , Enfermedades del Nervio Óptico/patología , Trastornos de la Visión/patologíaAsunto(s)
Inhibidores de la Angiogénesis/administración & dosificación , Anticuerpos Monoclonales Humanizados/administración & dosificación , Coriorretinitis/tratamiento farmacológico , Edema Macular/tratamiento farmacológico , Fiebre del Nilo Occidental/complicaciones , Anciano , Bevacizumab , Coriorretinitis/patología , Coriorretinitis/virología , Humanos , Inyecciones Intravítreas , Edema Macular/patología , Edema Macular/virología , MasculinoRESUMEN
Hepatitis C wirus is one of the major blood-born pathogens of huge epidemic value. Due to its easy transmission, lack of routinely pursued tests and long non-symptomatic period makes it crucial to be alert for all co-morbidites suggesting HCV infection. Consequently to reduce its farther transmission large knowledge of HCV should be spread as there is still no effective means of prophylaxis and its therapy is much costly. This article describes ophthalmic symptoms of hepatitis C virus infection such a mere keratoconiunctivitis sicca to ischemic retinopathy, macular edema and ischemic neuropathy.
Asunto(s)
Oftalmopatías/virología , Hepatitis C/complicaciones , Antivirales/uso terapéutico , Medicina Basada en la Evidencia , Oftalmopatías/tratamiento farmacológico , Infecciones Virales del Ojo/virología , Hepatitis C/tratamiento farmacológico , Humanos , Queratoconjuntivitis Seca/virología , Edema Macular/virología , Neuropatía Óptica Isquémica/virología , Enfermedades de la Retina/virologíaRESUMEN
PURPOSE: To investigate the clinical features associated with immune recovery in human immunodeficiency virus (HIV)-infected patients with cytomegalovirus retinitis who are taking highly active antiretroviral therapy. METHODS: Sixteen patients were evaluated prospectively at the National Eye Institute, Bethesda, Maryland. Evaluation included a medical history and a complete ophthalmologic examination. The examination included best-corrected visual acuity score measured by means of logarithmic charts, slit-lamp biomicroscopy, dilated retinal examination, retinal photography, and fluorescein angiography. Immune-recovery uveitis was defined as the ocular inflammation associated with clinical immune recovery in patients taking potent antiretroviral regimens. The ophthalmic characteristics of immune-recovery uveitis were identified, and their effect on visual acuity was statistically analyzed. RESULTS: The mean CD4+ T-lymphocyte count for the 16 patients taking highly active antiretroviral therapy at the time of evaluation was 393 cells/microl (range, 97-1,338 cells/microl). Immune-recovery uveitis was characterized by vitreitis and optic disk and macular edema. Clinically important complications of immune-recovery uveitis included cataract and epiretinal membrane formation. The visual acuity scores were significantly worse in the 23 eyes with cytomegalovirus retinitis (mean, 67.2 letters, 20/50) than in the nine eyes without cytomegalovirus retinitis (mean, 89.8 letters, 20/16) (P <.001). Regression analysis showed that a lower visual acuity score was associated with the presence of moderate to severe macular edema on fluorescein angiography and vitreous haze (P < or =. 001). CONCLUSIONS: Immune-recovery uveitis is an important cause of visual morbidity in HIV-infected patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Although immune recovery associated with highly active antiretroviral therapy has allowed some patients to discontinue specific anticytomegalovirus therapy, the rejuvenated immune response can be associated with sight-threatening inflammation.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/inmunología , Antivirales/uso terapéutico , Linfocitos T CD4-Positivos/fisiología , Retinitis por Citomegalovirus/inmunología , Uveítis/inmunología , Infecciones Oportunistas Relacionadas con el SIDA/tratamiento farmacológico , Infecciones Oportunistas Relacionadas con el SIDA/virología , Adulto , Terapia Antirretroviral Altamente Activa , Recuento de Linfocito CD4 , Retinitis por Citomegalovirus/tratamiento farmacológico , Retinitis por Citomegalovirus/virología , Oftalmopatías/tratamiento farmacológico , Oftalmopatías/inmunología , Oftalmopatías/virología , Angiografía con Fluoresceína , Estudios de Seguimiento , Fondo de Ojo , Humanos , Sistema Inmunológico/fisiología , Edema Macular/tratamiento farmacológico , Edema Macular/inmunología , Edema Macular/virología , Persona de Mediana Edad , Papiledema/tratamiento farmacológico , Papiledema/inmunología , Papiledema/virología , Estudios Prospectivos , Uveítis/tratamiento farmacológico , Uveítis/virología , Agudeza Visual , Cuerpo Vítreo/efectos de los fármacos , Cuerpo Vítreo/inmunología , Cuerpo Vítreo/virologíaAsunto(s)
Anticuerpos Anti-HTLV-I/análisis , Anticuerpos Anti-HTLV-II/análisis , Cristalino , Edema Macular/inmunología , Flebitis/inmunología , Enfermedades de la Retina/inmunología , Vena Retiniana , Cuerpo Vítreo/inmunología , Oftalmopatías/inmunología , Humanos , Edema Macular/virología , Flebitis/virología , Enfermedades de la Retina/virología , SíndromeRESUMEN
BACKGROUND: Although cystoid macular oedema (CMO) is a rare cause of visual loss in AIDS related cytomegalovirus (CMV) retinitis, nine cases are reported of CMO occurring in HIV infected patients with a prior diagnosis of CMV who were receiving highly active antiretroviral therapy (HAART). METHODS: Medical and ophthalmological records of nine AIDS patients with inactive CMV retinitis were retrospectively analysed. Ophthalmic examination data, laboratory findings, and the systemic antiviral treatment were studied. Ophthalmic examination included visual acuity, anterior chamber flare measured with the laser flare cell meter (LCFM), vitreous haze quantification according to the Nussenblatt grading system, and fluorescein angiography. RESULTS: Nine HIV infected patients, eight men and one woman, mean age 39 years (range 29-53 years) presented with inactive CMV retinitis and CMO. On fluorescein angiography, CMO was present only in eyes (14 eyes) with signs of previous CMV retinitis. CMV retinitis was inactive in all of them. Visual acuity ranged from 20/200 to 20/30. In 10 eyes with CMV retinitis, anterior chamber flare measured with the LCFM ranged from 18.5 to 82 photons/ms (mean 35.42 ph/ms). A significant vitreous inflammation (1.5+) was observed in eight eyes. All patients had been treated with anti-CMV drugs for a mean period of 18 months (range 12-36 months). All nine patients received HAART with a combination of two nucleotide analogue reverse transcriptase inhibitors and one protease inhibitor for a mean period of 14 months (range 9-18 months). The HIV viral load was below detectable levels (< 200 copies/ml) in eight patients and low (3215 copies/ml) in one. At the time of CMO, the median CD4+ lymphocyte count was 232 cells x 10(6)/l (range 99-639). CONCLUSION: In AIDS patients, the usual absence of intraocular inflammation in eyes affected by CMV retinitis has been tentatively explained by the profound cellular immunodeficiency. In these patients, treated with HAART, CD4+ counts were increased for several months (mean 14 months). In their eyes, CMV retinitis was associated with significant ocular inflammation and CMO. These findings could be related to the restoration of immune competence after HAART as recently shown.